# Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2

> **NCT02340299** · NA · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 6 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Newborn
- Respiratory Tract Diseases

## Interventions

- **DEVICE:** nHFOV
- **DEVICE:** nCPAP

## Key facts

- **NCT ID:** NCT02340299
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340299, "Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02340299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*